Adimab Announces Substantial Expansion of Research Campus
Adimab Provides 2023 Update on Clinical Pipeline
Adimab Provides Year-End Update on 2023 Partnership Activities
Adimab Announces Successful Resolution of Lawsuit Brought Against LinkedUp